Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Pacira Pharmaceuticals buy Truist Financial Co.

Pacira Pharmaceuticals
Start price
€18.90
25.07.25 / 50%
Target price
€25.55
25.07.26
Performance (%)
5.82%
Price
€19.70
09.10.25
Summary
This prediction is currently active. With a performance of 5.82%, the BUY prediction by Truist_Financial_Co_ for Pacira Pharmaceuticals is trending in the right direction. This prediction currently runs until 25.07.26. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Pacira Pharmaceuticals -4.369% -4.369%
iShares Core DAX® 0.641% 3.579%
iShares Nasdaq 100 2.167% 6.631%
iShares Nikkei 225® 4.902% 9.562%
iShares S&P 500 1.672% 4.814%

Comments by Truist_Financial_Co_ for this prediction

In the thread Pacira Pharmaceuticals diskutieren
Prediction Buy
Perf. (%) 5.82%
Target price 25.551
Change
Ends at 25.07.26

Pacira BioSciences, Inc. (NASDAQ: PCRX) was upgraded by analysts at Truist Financial Corporation from a "hold" rating to a "buy" rating. They now have a $30.00 price target on the stock.
Ratings data for PCRX provided by MarketBeat

Truist Financial Co. 
0
Report Share
25.07.25

Stopped prediction by Truist_Financial_Co_ for Pacira Pharmaceuticals

buy
Pacira Pharmaceuticals

Start price
Target price
Perf. (%)
€18.40
25.07.24
€27.62
25.07.25
2.17%
26.07.25

Truist Financial Co. 
25.07.24 50%